Physician profile
Georgette J Mccance
NPI 1164410452
$1,721.11
in general payments reported to CMS, 2019-2025
24 companies · $293 in 2025
The $293 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2020: $92.78 · 2021: $163 · 2022: $309 · 2023: $350 · 2024: $381 · 2025: $293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $894 · Education: $130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $893.88 |
| Education | $130.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $252.87 | 2023-2025 | Veozah |
| Abbvie INC. | $186.15 | 2019-2023 | |
| Millicent US INC | $152.01 | 2024-2025 | Intrarosa |
| Organon LLC | $102.92 | 2021-2024 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $102.56 | 2019-2025 | |
| Hologic Sales and Service, LLC | $102.49 | 2023-2024 | Acessa Provu System, Novasure, Omni Hysteroscope |
| Exeltis, USA INC. | $92.52 | 2021-2023 | Slynd |
| Pfizer INC. | $88.15 | 2022-2023 | |
| Lupin INC. | $77.03 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $72.93 | 2021-2025 | |
| Agile Therapeutics, INC. | $62.33 | 2021-2023 | Twirla |
| Coopersurgical, INC. | $58.51 | 2022-2024 | Summit Doppler, Paragard T 380a |
| Evofem Biosciences, INC. | $57.08 | 2022 | |
| Smith+Nephew, INC. | $50.70 | 2023-2024 | Pico 14, Renasys Go V2 Home |
| Ascend Therapeutics US, LLC | $36.61 | 2022-2023 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Channel Medsystems, INC. | $36.36 | 2023 | |
| Daiichi Sankyo INC. | $33.27 | 2019-2024 | Injectafer |
| Amgen INC. | $32.59 | 2024-2025 | Evenity, Prolia |
| Therapeuticsmd, INC. | $28.83 | 2020 | |
| Amag Pharmaceuticals, INC. | $23.90 | 2019-2020 | |
| Sage Therapeutics, LLC | $22.59 | 2025 | Zurzuvae |
| Meditrina | $21.60 | 2025 | |
| Mylan Pharmaceuticals INC. | $14.93 | 2020 | |
| Avion Pharmaceuticals | $12.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Georgette Mccance listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.